Targeted regulation of transcript stability through RNA methylation and intron retention
通过 RNA 甲基化和内含子保留来靶向调节转录稳定性
基本信息
- 批准号:10476700
- 负责人:
- 金额:$ 8.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBiological ProcessBiologyCell NucleusCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsCo-ImmunoprecipitationsCommunitiesComplexCytoplasmDataDissectionFoundationsGene ExpressionGene Expression RegulationGenetic EpistasisGenetic TranscriptionGenomeGoalsHealthHumanInterdisciplinary StudyIntronsKnowledgeLabelLife Cycle StagesMass Spectrum AnalysisMeasurementMeasuresMediatingMethylationMethyltransferaseModelingModificationMolecularMutagenesisNatureNuclearNuclear ExportNuclear RNANucleoproteinsPathway interactionsPlayPost-Transcriptional RegulationProcessProteinsPublic HealthRNARNA DecayRNA DegradationRNA EditingRNA ProcessingRNA SplicingRNA StabilityRNA methylationRNA-Binding ProteinsRegulationRegulatory PathwayRegulonReporterResearchRoleSet proteinSpliceosomesStructureSystemTechniquesTechnologyTestingTranscriptbasecell behaviorcomputerized toolsds RNA-Binding Proteinsexosomeexperimental studygenome editinghuman diseaseinsightinterdisciplinary approachinterestloss of functionmRNA Surveillancenovelprogramsprotein expressionrecruittool developmenttranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Cells rely on spatially and temporally precise expression of proteins to carry out key biological processes.
Thus, decoding the regulatory genome is a crucial step towards developing accurate models of cellular
behavior. While transcriptional networks have been widely studied, post-transcriptional regulatory programs
remain largely uncharacterized. Recently, we discovered the double-stranded RNA-binding protein TARBP2
acts as a global regulator of RNA stability (Goodarzi et al. Nature, 2014). However, the underlying molecular
mechanisms through which this non-canonical TARBP2 pathway regulates RNA decay were unknown. Based
on our observation that TARBP2 binds extensively to the intronic regions of its target transcripts, we
hypothesized and successfully demonstrated that this decay pathway is located in the nucleus. We also
showed that TARBP2 interacts with different sets of proteins in the nucleus and the cytoplasm. Interestingly,
among the nucleus-specific interactions were key components of the RNA methyltransferase complex and the
nuclear surveillance machinery. Our preliminary findings strongly support a model in which TARBP2 binding
results in the recruitment of the RNA methyltransferase complex and the subsequent methylation of TARBP2-
bound introns. Methylated introns, which remain unspliced, are then targeted to the RNA exosome for
degradation through an interaction between TARBP2 and the nucleoprotein TPR.
To assess the veracity of this model, we will perform nuclear RNA sequencing to measure intron retention in
the presence and absence of different components of this pathway. First, we will assess the role of TARBP2
binding in RNA methylation and its impact on splicing. Then, we will search for the components of the nuclear
surveillance machinery that degrade transcripts with TARBP2-bound introns. We will also perform epistasis
experiments to establish the pathway structure for this process. At every step, in addition to whole-
transcriptomic measurements, we will use reporter constructs and CRISPR-mediated genome editing to test
the requirement and sufficiency of TARBP2 binding, RNA methylation, and splicing in RNA decay.
The successful completion of this study will result in the characterization of a novel regulatory pathway that
uses targeted RNA methylation and orchestrated intron retention to modulate RNA abundance. The study
proposed here builds on our years of multidisciplinary research on post-transcriptional regulation of gene
expression (Goodarzi et al, Cell 2015, 2016; Goodarzi et al, Nature 2012, 2014). Our preliminary results, which
strongly support our proposed model, provide a strong foundation for the interdisciplinary approach outlined in
this proposal. Given our strong background in computational and experimental biology, and the expertise and
support provided by our collaborators at UCSF, we are ideally situated to tackle this project.
项目摘要
细胞依赖于蛋白质在空间和时间上的精确表达来进行关键的生物过程。
因此,解码调控基因组是开发精确的细胞模型的关键一步。
行为虽然转录网络已被广泛研究,转录后调控程序,
基本上没有特征。最近,我们发现了双链RNA结合蛋白TARBP 2
作为RNA稳定性的全局调节剂(Goodarzi等人,Nature,2014)。然而,
这种非经典的TARBP 2途径调节RNA衰变的机制是未知的。基于
根据我们观察到的TARBP 2与其靶转录物的内含子区域广泛结合的结果,
假设并成功地证明了这种衰变途径位于原子核中。我们也
结果表明,TARBP 2与细胞核和细胞质中的不同蛋白质组相互作用。有趣的是,
在核特异性相互作用中,RNA甲基转移酶复合物和
核监视机器。我们的初步研究结果强烈支持一个模型,其中TARBP 2结合
导致RNA甲基转移酶复合物的募集和随后的TARBP 2-甲基化。
结合内含子保持未剪接的甲基化内含子然后靶向RNA外泌体,
通过TARBP 2和核蛋白TPR之间的相互作用降解。
为了评估该模型的准确性,我们将进行核RNA测序,以测量内含子保留,
该途径不同组分的存在和不存在。首先,我们将评估TARBP 2的作用
RNA甲基化的结合及其对剪接的影响。然后,我们将寻找核武器的组成部分,
监控机制,降解转录与TARBP 2结合的内含子。我们还将执行上位
实验来建立这个过程的路径结构。在每一步,除了整个-
转录组学测量,我们将使用报告构建体和CRISPR介导的基因组编辑来测试
RNA降解中TARBP 2结合、RNA甲基化和剪接的需要和充分性。
这项研究的成功完成将导致一种新的调控途径的表征,
使用靶向RNA甲基化和协调的内含子保留来调节RNA丰度。研究
基于我们多年来对基因转录后调控的多学科研究,
表达(Goodarzi等,Cell 2015,2016; Goodarzi等,Nature 2012,2014)。我们的初步结果,
强烈支持我们提出的模式,为跨学科方法提供了坚实的基础,
这个提议。鉴于我们在计算和实验生物学方面的强大背景,以及我们的专业知识和
在UCSF的合作者的支持下,我们非常适合解决这个项目。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis.
- DOI:10.1038/s41586-020-2774-y
- 发表时间:2020-10
- 期刊:
- 影响因子:64.8
- 作者:Tavora B;Mederer T;Wessel KJ;Ruffing S;Sadjadi M;Missmahl M;Ostendorf BN;Liu X;Kim JY;Olsen O;Welm AL;Goodarzi H;Tavazoie SF
- 通讯作者:Tavazoie SF
Massively multiplex single-molecule oligonucleosome footprinting.
- DOI:10.7554/elife.59404
- 发表时间:2020-12-02
- 期刊:
- 影响因子:7.7
- 作者:Abdulhay NJ;McNally CP;Hsieh LJ;Kasinathan S;Keith A;Estes LS;Karimzadeh M;Underwood JG;Goodarzi H;Narlikar GJ;Ramani V
- 通讯作者:Ramani V
Orthogonally induced differentiation of stem cells for the programmatic patterning of vascularized organoids and bioprinted tissues.
- DOI:10.1038/s41551-022-00856-8
- 发表时间:2022-04
- 期刊:
- 影响因子:28.1
- 作者:
- 通讯作者:
C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer.
- DOI:10.1038/s41467-021-27734-2
- 发表时间:2022-01-10
- 期刊:
- 影响因子:16.6
- 作者:Liu XZ;Rulina A;Choi MH;Pedersen L;Lepland J;Takle ST;Madeleine N;Peters SD;Wogsland CE;Grøndal SM;Lorens JB;Goodarzi H;Lønning PE;Knappskog S;Molven A;Halberg N
- 通讯作者:Halberg N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hani Goodarzi其他文献
Hani Goodarzi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hani Goodarzi', 18)}}的其他基金
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
利用培养皿中异质 ALS 群体的自然表型变异来实现可扩展的药物发现
- 批准号:
10478452 - 财政年份:2022
- 资助金额:
$ 8.95万 - 项目类别:
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
利用培养皿中异质 ALS 群体的自然表型变异来实现可扩展的药物发现
- 批准号:
10706307 - 财政年份:2022
- 资助金额:
$ 8.95万 - 项目类别:
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression
编辑 CG 和非 CG DNA 甲基化以识别调节基因表达的基因组元件
- 批准号:
10655625 - 财政年份:2021
- 资助金额:
$ 8.95万 - 项目类别:
The RNA structural code underlying pathological regulation of RNA splicing in metastasis
转移中RNA剪接病理调控的RNA结构密码
- 批准号:
10654522 - 财政年份:2021
- 资助金额:
$ 8.95万 - 项目类别:
The RNA structural code underlying pathological regulation of RNA splicing in metastasis
转移中RNA剪接病理调控的RNA结构密码
- 批准号:
10358636 - 财政年份:2021
- 资助金额:
$ 8.95万 - 项目类别:
The RNA structural code underlying pathological regulation of RNA splicing in metastasis
转移中RNA剪接病理调控的RNA结构密码
- 批准号:
10117466 - 财政年份:2021
- 资助金额:
$ 8.95万 - 项目类别:
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression
编辑 CG 和非 CG DNA 甲基化以识别调节基因表达的基因组元件
- 批准号:
10487529 - 财政年份:2021
- 资助金额:
$ 8.95万 - 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
- 批准号:
10435493 - 财政年份:2019
- 资助金额:
$ 8.95万 - 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
- 批准号:
10652579 - 财政年份:2019
- 资助金额:
$ 8.95万 - 项目类别:
Alzheimer's Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis
阿尔茨海默氏症行政补充——一种驱动癌症转移的反义 RNA 介导的调控程序
- 批准号:
10117474 - 财政年份:2019
- 资助金额:
$ 8.95万 - 项目类别:
相似海外基金
Nitrous Oxide Management in a Novel Biological Process
新型生物过程中的一氧化二氮管理
- 批准号:
2789227 - 财政年份:2023
- 资助金额:
$ 8.95万 - 项目类别:
Studentship
Dynamic regulation of RNA modification and biological process
RNA修饰和生物过程的动态调控
- 批准号:
18H05272 - 财政年份:2018
- 资助金额:
$ 8.95万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2017
- 资助金额:
$ 8.95万 - 项目类别:
Discovery Grants Program - Individual
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2016
- 资助金额:
$ 8.95万 - 项目类别:
Discovery Grants Program - Individual
Organizing the Waterloo Biofilter biological process for treating wastewater concentrated by extreme water conservation plumbing
组织滑铁卢生物过滤器生物工艺处理通过极端节水管道浓缩的废水
- 批准号:
479764-2015 - 财政年份:2015
- 资助金额:
$ 8.95万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2015
- 资助金额:
$ 8.95万 - 项目类别:
Discovery Grants Program - Individual
Development of Biological Process for VOC treatment
VOC处理生物工艺的开发
- 批准号:
476672-2014 - 财政年份:2015
- 资助金额:
$ 8.95万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2014
- 资助金额:
$ 8.95万 - 项目类别:
Discovery Grants Program - Individual
Optimization of a biological process treating winery wastewater: anaerobic digestion integrated with Waterloo biofilter
处理酿酒厂废水的生物工艺优化:厌氧消化与滑铁卢生物过滤器集成
- 批准号:
463193-2014 - 财政年份:2014
- 资助金额:
$ 8.95万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2013
- 资助金额:
$ 8.95万 - 项目类别:
Discovery Grants Program - Individual